查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
DNA甲基化检测技术的全球市场（2023-2033）：按技术、应用、最终用户、产品类型和国家分類的分析、预测和竞争形势
市场调查报告书
商品编码
1429207

DNA甲基化检测技术的全球市场（2023-2033）：按技术、应用、最终用户、产品类型和国家分類的分析、预测和竞争形势

Global DNA Methylation Detection Technology Market: Focus on Technology, Application, End User, Product Type, Country Level Analysis and Competitive Landscape - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 109 Pages | 商品交期: 1-5个工作天内

价格

全球DNA甲基化检测技术市场规模预计将从2023年的28亿美元成长到2033年的123.2亿美元，预测期间内复合年增长率为15.96%。

该市场的成长是由于越来越多地采用 DNA 甲基化检测技术作为磊晶生物标记、学术机构之间研究合作的增加以及生物技术和製药行业新兴企业数量的增加。是

主要市场统计数据
预测期 2023-2033
2023年评估 28亿美元
2033年预测 123.2亿美元
复合年增长率 15.96%

全球DNA甲基化检测技术市场被认为处于其生命週期的成熟成长期。在研究和临床环境中越来越多地采用 DNA 甲基化分析工具和技术的推动下，市场正在迅速扩大。人们对 DNA 甲基化在各种生物过程和疾病中的作用的日益了解，加上检测方法和分析平台的进步，正在推动市场成长。此外，对个人化医疗和精准诊断的需求不断增长，进一步加速了市场扩张。随着越来越多的参与企业市场，竞争加剧，但创新、产品开发和市场渗透的机会也比比皆是。

按产品划分，消耗品类别在 2022 年占据市场主导地位。对亚硫酸氢盐转化套件、PCR 试剂和定序文库等消耗品的持续需求推动了需求的成长。此外，从技术角度来看，PCR 领域在 2022 年占据了最大的市场份额。由于其广泛采用、多功能性和可靠性，PCR 方法预计将保持其在全球市场的主导地位。

本报告调查了全球DNA甲基化检测技术市场，并提供了市场概况，分析了市场成长的各种影响因素、技术和专利趋势、临床试验趋势、法律制度以及市场规模趋势和预测。国家、主要企业分析等

目录

执行摘要

第一章 市场

  • 趋势：当前和未来的影响评估
    • 主要趋势
    • 亚硫酸氢盐转化成为全球 DNA 甲基化检测技术市场的黄金标准
    • 拓展 DNA 甲基化检测技术的临床研究应用
  • 供应链概览
    • 价值链分析
    • 市场地图
  • 研发回顾
    • 专利申请趋势（按国家/公司）
  • 监管状况
  • 全球重大事件的影响分析：COVID-19
  • 市场动态概览
    • 市场驱动因素
    • 市场限制因素
    • 市场机会

第二章 应用

  • 使用分类
  • 全球DNA甲基化检测技术市场（依技术）
    • 聚合酵素链锁反应(PCR)
    • 微阵列
    • 顺序
    • 其他的
  • 全球DNA甲基化检测技术市场（依应用）
    • 转化研究
    • 诊断
  • 全球DNA甲基化检测技术市场（依最终用户）
    • 受託研究机构（CRO）
    • 研究和学术机构
    • 生物製药和生物技术公司
    • 其他的

第三章 产品

  • 产品分类
  • 产品概要
  • 产品类别
    • 市场概况
  • 全球DNA甲基化检测技术市场（依产品类型）
    • 消耗品
    • 装置
    • 软体

第四章 区域

  • 区域概况
  • 促进因素/抑制因素
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 其他地区
    • 区域概况
    • 市场成长动力
    • 市场问题
    • 国家分析

第五章市场：竞争基准化分析与公司概况

  • 下一个前沿
  • 地理评估
    • Agilent Technologies, Inc.
    • Abcam plc.
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • Qiagen NV
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Pacific Biosciences of California, Inc.
    • Exact Sciences Corporation
    • Merck KGaA
    • Enzo Life Sciences, Inc.
    • Takara Bio Inc.
    • Revvity, Inc. (PerkinElmer, Inc.)
    • New England Biolabs

第六章调查方法

Product Code: BHP1769SA

The Global DNA Methylation Detection Technology Market Expected to Reach $12.32 Billion by 2033

Global DNA Methylation Detection Technology Market Overview

The global DNA methylation detection technology market is projected to experience substantial growth over the forecast period 2023-2033. Moreover, the market value for 2023 was $2.80 billion, which is expected to reach $12.32 billion by 2023, growing at a CAGR of 15.96% during the forecast period. This growth can be attributed to the increasing adoption of DNA methylation detection technology as epigenetic biomarkers, increasing collaborations between academic institutions, and rising startups in the biotechnology and pharmaceutical industry. The market includes various consumables, instruments, and software.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$2.80 Billion
2033 Forecast$12.32 Billion
CAGR15.96%

Market Lifecycle Stage

The global DNA methylation detection technology market can be considered to be in the mature growth stage of its lifecycle. This stage is characterized by rapid market expansion, driven by the increasing adoption of DNA methylation analysis tools and technologies in both research and clinical settings. The growing understanding of the role of DNA methylation in various biological processes and diseases, coupled with advancements in detection methods and analytical platforms, fuels the market's growth. Additionally, the rising demand for personalized medicine and precision diagnostics further accelerates market expansion. While competition intensifies as more players enter the market, opportunities for innovation, product development, and market penetration abound.

Industry Impact

The global DNA methylation detection technology market has made a profound impact across various industries, revolutionizing healthcare, biotechnology, pharmaceuticals, and research. By enabling the identification of epigenetic biomarkers associated with disease susceptibility, progression, and treatment response, these technologies have advanced precision medicine approaches, allowing for personalized treatment strategies tailored to individual patient's genetic and epigenetic profiles. In drug discovery and development, DNA methylation analysis accelerates the identification of novel drug targets, biomarkers for patient stratification, and predictors of drug response, leading to the development of more effective and safer therapies. Moreover, these technologies are increasingly used in clinical diagnostics for early disease detection, diagnosis, and prognosis, offering high sensitivity and specificity for improved patient outcomes.

The global DNA methylation detection technology market continues to drive transformative advancements across industries, with far-reaching implications for human health and environmental sustainability.

Market Segmentation:

Segmentation 1: by Product

  • Consumables
  • Instruments
  • Software

Consumables to Dominate the Global DNA Methylation Detection Technology Market (by Product)

Based on product, the consumables segment dominated the global DNA methylation detection technology market in FY2022. The recurring need for consumables such as bisulfite conversion kits, PCR reagents, and sequencing libraries drives continuous demand. Secondly, the increasing adoption of high-throughput methods such as next-generation sequencing and microarray analysis requires large quantities of consumables to process samples efficiently. Additionally, as research and clinical applications of DNA methylation analysis expand, the demand for consumables is expected to grow steadily, further solidifying their dominance in the market.

Segmentation 2: by Technology

  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Sequencing
  • Other Technologies

PCR to Hold its Dominance in the Global DNA Methylation Detection Technology Market (by Technology)

Based on technology, the PCR segment accounted for the largest share of the global DNA methylation detection technology market in FY2022. Moreover, PCR is expected to maintain its dominance in the global DNA methylation detection technology market by technology due to its widespread adoption, versatility, and reliability. PCR-based methods, such as methylation-specific PCR (MSP) and quantitative real-time PCR (qPCR), offer high sensitivity and specificity for detecting DNA methylation patterns, making them essential tools in epigenetic research and clinical diagnostics.

Segmentation 3: by Application

  • Translational Research
  • Diagnostic Procedure

Diagnostic Procedure to Hold its Dominance in the Global DNA Methylation Detection Technology Market (by Application)

Based on application, diagnostic research accounted for the largest share of the global DNA methylation detection technology market in FY2022, primarily due to clinicians' increasing focus on utilizing DNA methylation analysis for clinical diagnostics. DNA methylation patterns have been extensively studied as potential biomarkers for various diseases, including cancer, neurological disorders, and autoimmune conditions.

Segmentation 4: by End User

  • Contract Research Organization (CRO)
  • Research and Academic Laboratories
  • Biopharmaceutical and Biotech Companies
  • Other End User

Biopharmaceutical and Biotech Companies Segment to Hold its Dominance in the Global DNA Methylation Detection Technology Market (by End User)

Based on end user, the biopharmaceutical and biotech companies segment accounted for the largest share of the global DNA methylation detection technology market in FY2022 due to their extensive use of DNA methylation analysis in drug discovery, development, and personalized medicine applications.

Segmentation 5: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest-of-the-World

North America dominated the global DNA methylation detection technology market in 2022. Moreover, Asia-Pacific is expected to register the highest CAGR of 17.79% during the forecast period 2023-2033. The DNA methylation detection technology market in the Asia-Pacific (APAC) region is witnessing significant growth, driven by various factors, some of which include growing investment in epigenetics and biotechnology, a large population base driving demand for diagnostics, and others.

Recent Developments in the Global DNA Methylation Detection Technology Market

  • In August 2023, Pacific Biosciences of California, Inc., and GeneDx initiated a research collaboration with the University of Washington. This partnership focuses on studying the effectiveness of long-read whole genome sequencing in improving diagnostic accuracy in neonatal care.
  • In February 2023, Ultima Genomics, Inc. announced a partnership with New England Biolabs to integrate NEB's NEBNext reagents and library preparation kits into Ultima's sequencing platforms. This collaboration would develop and optimize next-generation sequencing (NGS) processes for DNA, RNA, and methylation sequencing applications.
  • In April 2022, Pacific Biosciences of California, Inc. announced the introduction of the new Revio long-read sequencing system. This system would significantly enhance the use of PacBio's acclaimed HiFi sequencing technology among its users, allowing for more extensive application.
  • In September 2021, Zymo Research Corporation announced that its EZ DNA methylation-lightning kit had been approved for use in the European Union (EU) with the CE IVD Mark. This approval would allow the distribution of the kit within the EU market. The kit's technology, which involves the chemical treatment of DNA with bisulfite, could prove to be essential for various methylation-based diagnostic assays.

Demand - Drivers, Restraints, and Opportunities

Market Demand Drivers:

Increasing Adoption of DNA Methylation Detection Technology as Epigenetic Biomarkers: The growing use of DNA methylation detection technology as epigenetic markers significantly drives the global market for DNA methylation detection technology. Its importance stems from its capabilities in the early detection of diseases, tailoring medical treatments to individual needs, and deepening one's understanding of how diseases develop. As research progresses and technology advances, DNA methylation is anticipated to play an increasingly vital role in healthcare, boosting the market's growth and expansion.

Market Restraints:

Complexity in Data Interpretation of DNA Methylation Data: The complexity of data interpretation in DNA methylation detection underscores the need for multidisciplinary collaboration involving molecular biologists, bioinformaticians, clinicians, and data scientists. It also highlights the importance of continuous research and development in the field to refine data analysis methodologies and enhance one's understanding of the epigenetic mechanisms underlying various diseases.

Market Opportunities:

Expansion of DNA Methylation Detection in Emerging Geographies: The expansion of DNA methylation detection technology in emerging geographies is expected to signify its global relevance and potential impact. In these regions, where healthcare infrastructure and resources may be more limited, DNA methylation detection could offer an efficient means of early disease diagnosis.

How can this report add value to an organization?

Workflow/Innovation Strategy: The global DNA methylation detection technology market (by product) has been segmented into detailed segments, including different types of consumables, such as kits and assays, reagents, and enzymes, as well as instruments and software.

Growth/Marketing Strategy: A strategic growth and marketing approach for the DNA methylation detection technology market would involve positioning the company as a leader in innovative solutions that address the evolving needs of researchers, clinicians, and pharmaceutical partners. This would entail leveraging technological advancements to develop cutting-edge products with enhanced sensitivity, specificity, and scalability while also investing in comprehensive customer support, training programs, and collaborative partnerships to foster customer loyalty and drive market penetration. Furthermore, targeted marketing campaigns highlighting the clinical relevance, cost-effectiveness, and competitive advantages of the company's offerings would help to increase brand visibility, attract new customers, and expand market share in this rapidly growing and dynamic industry.

Competitive Strategy: Key players in the global DNA methylation detection technology market have been focusing on innovation, differentiation, and strategic collaborations to gain a competitive edge. By investing in research and development, companies can develop novel detection methods, improve assay sensitivity, and expand application areas. Differentiation through the development of proprietary technologies, customizable solutions, and value-added services can help companies stand out in a crowded market, strengthen market positions, acquire new technologies, and broaden product portfolios.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2022. The historical year analysis has been done from FY2020 to FY2021, and the market size has been calculated for FY2022 and projected for the period 2023-2033.
  • The geographical distribution of the market revenue has been estimated to be the same as the company's net revenue distribution. All the numbers have been adjusted to two digits after decimals for report presentation reasons. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. CAGR has been calculated from 2023 to 2033.
  • The market has been mapped based on different types of products available in the market and based on several indications. All the key manufacturing companies that have a significant number of offerings to the global DNA methylation detection technology market have been considered and profiled in the report.
  • In the study, the primary respondent's verification has been considered to finalize the estimated market for the global DNA methylation detection technology market.
  • The latest annual reports of each market player have been taken into consideration for market revenue calculation.
  • Market strategies and developments of key players have been considered for the calculation of sub-segment split.
  • The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year. The currency conversion rate has been taken from the historical exchange rate of the Oanda website or from the annual reports of the respective company, if stated.

Primary Research

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding of the numbers of the various markets for market type
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • National Center for Biotechnology Information (NCBI), PubMed, Science Direct, World Bank Group, and World Health Organization (WHO)
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their portfolio
  • Gold standard magazines, journals, whitepapers, press releases, and news articles
  • Databases

The key data points taken from the secondary sources include:

  • Segmentations, split-ups, and percentage shares
  • Data for market value
  • Key industry trends of the top players in the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

In the DNA methylation detection technology market, several key players dominate the landscape with their diverse range of products and solutions. Thermo Fisher Scientific, Illumina, Inc. QIAGEN, Zymo Research Corporation, and Agilent Technologies, Inc. are among the prominent market players offering innovative tools and platforms for DNA methylation analysis. These companies provide bisulfite conversion kits, methylation-specific PCR assays, microarray platforms, next-generation sequencing solutions, and bioinformatics software to researchers and clinicians worldwide.

Competition in this market is fierce, driven by continuous technological innovation, expansion of product portfolios, effective marketing strategies, and a focus on regulatory compliance. Additionally, market players vie for market share by establishing strong customer support networks and ensuring high-quality service delivery. As the demand for DNA methylation detection technologies grows, competition intensifies, with companies striving to meet the evolving needs of the research and clinical communities while maintaining a competitive edge in the market.

Some of the prominent companies in this market are:

  • Agilent Technologies, Inc.
  • Abcam plc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Pacific Biosciences of California, Inc.
  • Exact Sciences Corporation
  • Merck KGaA
  • Enzo Life Sciences, Inc.
  • Takara Bio Inc.
  • Revvity, Inc. (PerkinElmer, Inc.)
  • New England Biolabs

Companies that are not a part of the aforementioned pool have been well represented across different sections of the report (wherever applicable).

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Key Trends
    • 1.1.2 Bisulfite Conversion as a Gold Standard in the Global DNA Methylation Detection Technology Market
    • 1.1.3 Expansion of DNA Methylation Detection Technology in Clinical Research Applications
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
    • 1.2.2 Market Map
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Global Events - COVID-19
  • 1.6 Market Dynamics Overview
    • 1.6.1 Market Drivers
      • 1.6.1.1 Increasing Adoption of DNA Methylation Detection Technology as Epigenetic Biomarkers
      • 1.6.1.2 Increasing Research and Development in Genomics and Epigenetics
      • 1.6.1.3 Technological Advancements in Detection Methods
    • 1.6.2 Market Restraints
      • 1.6.2.1 Complexity in Data Interpretation of DNA Methylation Data
      • 1.6.2.2 High Cost of DNA Methylation Detection Instruments and Various Kits and Assays
    • 1.6.3 Market Opportunities
      • 1.6.3.1 DNA Methylation Detection Technology as an Early Disease Diagnostic Tool
      • 1.6.3.2 Expansion of DNA Methylation Detection in Emerging Geographies

2 Application

  • 2.1 Application Segmentation
  • 2.2 Global DNA Methylation Detection Technology Market (by Technology)
    • 2.2.1 Polymerase Chain Reaction (PCR)
    • 2.2.2 Microarray
    • 2.2.3 Sequencing
    • 2.2.4 Other Technologies
  • 2.3 Global DNA Methylation Detection Technology Market (by Application)
    • 2.3.1 Translational Research
    • 2.3.2 Diagnostic Procedures
  • 2.4 Global DNA Methylation Detection Technology Market (by End User)
    • 2.4.1 Contract Research Organization (CRO)
    • 2.4.2 Research and Academic Institutions
    • 2.4.3 Biopharmaceutical and Biotech Companies
    • 2.4.4 Other End Users

3 Products

  • 3.1 Product Segmentation
  • 3.2 Product Summary
  • 3.3 Product Type
    • 3.3.1 Market Overview
      • 3.3.1.1 Analyst View
  • 3.4 Global DNA Methylation Detection Technology Market (by Product Type)
    • 3.4.1 Consumables
      • 3.4.1.1 Kits and Assays
      • 3.4.1.2 Reagents
      • 3.4.1.3 Enzymes
    • 3.4.2 Instruments
    • 3.4.3 Software

4 Regions

  • 4.1 Regional Summary
  • 4.2 Drivers and Restraints
  • 4.3 North America
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 U.S.
    • 4.3.5 Canada
  • 4.4 Europe
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Germany
    • 4.4.5 U.K.
    • 4.4.6 France
    • 4.4.7 Italy
    • 4.4.8 Spain
    • 4.4.9 Rest-of-Europe
  • 4.5 Asia-Pacific
    • 4.5.1 Regional Overview
    • 4.5.2 Driving Factors for Market Growth
    • 4.5.3 Factors Challenging the Market
    • 4.5.4 China
    • 4.5.5 Japan
    • 4.5.6 India
    • 4.5.7 Australia
    • 4.5.8 South Korea
    • 4.5.9 Rest-of-Asia-Pacific
  • 4.6 Latin America
    • 4.6.1 Regional Overview
    • 4.6.2 Driving Factors for Market Growth
    • 4.6.3 Factors Challenging the Market
    • 4.6.4 Brazil
    • 4.6.5 Mexico
    • 4.6.6 Rest-of-Latin America
  • 4.7 Rest-of-the-World
    • 4.7.1 Regional Overview
    • 4.7.2 Driving Factors for Market Growth
    • 4.7.3 Factors Challenging the Market

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Next Frontiers
  • 5.2 Geographic Assessment
    • 5.2.1 Agilent Technologies, Inc.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products/Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Key Personnel
      • 5.2.1.5 Analyst View
    • 5.2.2 Abcam plc.
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products/Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Key Personnel
      • 5.2.2.5 Analyst View
    • 5.2.3 Bio-Rad Laboratories, Inc.
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products/Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Key Personnel
      • 5.2.3.5 Analyst View
    • 5.2.4 Illumina, Inc.
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products/Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Key Personnel
      • 5.2.4.5 Analyst View
    • 5.2.5 Qiagen N.V.
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products/Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Key Personnel
      • 5.2.5.5 Analyst View
    • 5.2.6 Thermo Fisher Scientific, Inc.
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products/Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Key Personnel
      • 5.2.6.5 Analyst View
    • 5.2.7 F. Hoffmann-La Roche Ltd.
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products/Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Key Personnel
      • 5.2.7.5 Analyst View
    • 5.2.8 Hologic, Inc.
      • 5.2.8.1 Overview
      • 5.2.8.2 Top Products/Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Key Personnel
      • 5.2.8.5 Analyst View
    • 5.2.9 Pacific Biosciences of California, Inc.
      • 5.2.9.1 Overview
      • 5.2.9.2 Top Products/Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Key Personnel
      • 5.2.9.5 Analyst View
    • 5.2.10 Exact Sciences Corporation
      • 5.2.10.1 Overview
      • 5.2.10.2 Top Products/Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Key Personnel
      • 5.2.10.5 Analyst View
    • 5.2.11 Merck KGaA
      • 5.2.11.1 Overview
      • 5.2.11.2 Top Products/Product Portfolio
      • 5.2.11.3 Top Competitors
      • 5.2.11.4 Key Personnel
      • 5.2.11.5 Analyst View
    • 5.2.12 Enzo Life Sciences, Inc.
      • 5.2.12.1 Overview
      • 5.2.12.2 Top Products/Product Portfolio
      • 5.2.12.3 Top Competitors
      • 5.2.12.4 Key Personnel
      • 5.2.12.5 Analyst View
    • 5.2.13 Takara Bio Inc.
      • 5.2.13.1 Overview
      • 5.2.13.2 Top Products/Product Portfolio
      • 5.2.13.3 Top Competitors
      • 5.2.13.4 Key Personnel
      • 5.2.13.5 Analyst View
    • 5.2.14 Revvity, Inc. (PerkinElmer, Inc.)
      • 5.2.14.1 Overview
      • 5.2.14.2 Top Products/Product Portfolio
      • 5.2.14.3 Top Competitors
      • 5.2.14.4 Key Personnel
      • 5.2.14.5 Analyst View
    • 5.2.15 New England Biolabs
      • 5.2.15.1 Overview
      • 5.2.15.2 Top Products/Product Portfolio
      • 5.2.15.3 Top Competitors
      • 5.2.15.4 Key Personnel
      • 5.2.15.5 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global DNA Methylation Detection Technology Market (by Region), $Billion, 2022, 2026, and 2033
  • Figure 2: Global DNA Methylation Detection Technology Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 3: Number of Methylation Analysis Publications, in Thousands, 2002-2020
  • Figure 4: Number of Commercially Available Methylation Tests (by Application Areas)
  • Figure 5: Global DNA Methylation Detection Technology Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 6: Global DNA Methylation Detection Technology Market (by Technology), $Million, 2022, 2026, and 2033
  • Figure 7: Global DNA Methylation Detection Technology Market (by Product Type), $Million, 2022, 2026, and 2033
  • Figure 8: Global DNA Methylation Detection Technology Market, Recent Developments
  • Figure 9: Supply Chain and Risks within the Supply Chain
  • Figure 10: Global DNA Methylation Detection Technology Market (by Country), January 2021-December 2023
  • Figure 11: Global DNA Methylation Detection Technology Market (by Year), January 2021-December 2023
  • Figure 12: Impact of COVID-19 on DNA Methylation Detection Technology
  • Figure 13: Impact Analysis of Market Navigating Factors, 2022-2033
  • Figure 14: Advantage of DNA Methylation as Epigenetic Biomarkers
  • Figure 15: Analyzing the Differences: IColocomf vs. FIT and Colonoscopy
  • Figure 16: Evolution in Next-Generation Sequencing (NGS)Techniques for DNA Methylation Analysis, 2005-2021
  • Figure 17: Factors Responsible for Complexity in Data Interpretation
  • Figure 18: Pricing Analysis of Major DNA Methylation Detection Kits and Assays
  • Figure 19: Startups Working in Epigenomics Research
  • Figure 20: Table: Global DNA Methylation Detection Technology Market (by Product Type)
  • Figure 21: U.S. DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 22: Canada DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 23: Germany DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 24: U.K. DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 25: France DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 26: Italy DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 27: Spain DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 28: China DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 29: Japan DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 30: Australia DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 31: South Korea DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 32: Rest-of-Asia-Pacific DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 33: Brazil DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 34: Mexico DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 35: Rest-of-Latin America DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Figure 36: Strategic Initiatives, 2019-2023
  • Figure 37: Share of Strategic Initiatives, 2019-2023
  • Figure 38: Data Triangulation
  • Figure 39: Top-Down and Bottom-Up Approach
  • Figure 40: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Global DNA Methylation Detection Technology Market, Opportunities
  • Table 3: Market Share of Key Companies, 2022
  • Table 4: Global DNA Methylation Detection Technology Market, Product Benchmarking
  • Table 5: Examples of Increasing Research in the DNA Methylation Detection Technology Industry
  • Table 6: Key Companies and Technological Advancements, 2019-2023
  • Table 7: Global DNA Methylation Detection Technology Market (by Technology), $Million, 2022-2033
  • Table 8: Global DNA Methylation Detection Technology Market (by Application), $Million, 2022-2033
  • Table 9: Global DNA Methylation Detection Technology Market (by End User), $Million, 2022-2033
  • Table 10: Global DNA Methylation Detection Technology Market (by Product Type), $Million, 2022-2033
  • Table 11: Global DNA Methylation Detection Technology Market (by Consumables), $Million, 2022-2033
  • Table 12: Global DNA Methylation Detection Technology Market (by Region), $Million, 2022-2033
  • Table 13: Rest-of-Europe DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Table 14: India DNA Methylation Detection Technology Market, $Million, 2022-2033
  • Table 15: Company Market Share, 2022